Parasomnias are sleep disorders involving undesirable physical events or experiences occurring during sleep onset, while sleeping, or on arousal. They include non–rapid eye movement (REM) parasomnias (eg, confusional arousals, sleep terrors, sleepwalking) and REM–related parasomnias (eg, nightmare disorder, REM sleep behavior disorder, sleep paralysis). Notable among these is REM sleep behavior disorder, which is closely linked to neurodegenerative conditions such as Parkinson disease. Early detection of this disorder is essential because it often precedes the motor symptoms of neurodegenerative conditions. Diagnostic evaluation of parasomnias typically involves polysomnography, in some cases with video monitoring, to differentiate parasomnias from other conditions. Nonpharmacologic treatments, including sleep hygiene and sleep safety measures, are first-line approaches. Cognitive behavior therapy is also effective. Pharmacotherapy may be required in severe cases. Referral to a sleep specialist is recommended for patients with complex or dangerous parasomnias and for patients with frequent sleep paralysis.

Case 3. FT is a 62-year-old man who comes to your office concerned about acting out his nightmares. His wife reports that several times in the past 3 months, FT has begun violently thrashing around in bed and yelling in the middle of the night. Once, he jumped out of bed and bruised his forehead on the nightstand but had no memory of the episode the following morning. FT takes for hypertension and sertraline for depression. He reports no prior difficulty sleeping.

Definition and Prevalence

The American Academy of Sleep Medicine International Classification of Sleep Disorders, 3rd ed., text revision, defines parasomnias as undesirable physical events or experiences occurring during sleep onset, while sleeping, or on arousal. These events can occur in non–rapid eye movement (NREM) sleep, in REM sleep, or during transitions between sleep and wakefulness.1 Parasomnias are prevalent across all ages, with certain types more common in specific populations.

Early detection of and intervention for parasomnias are crucial to reducing their health effects as they are linked to underlying conditions such as sleep-related breathing disorders, including obstructive sleep apnea (OSA).2 Recognizing this connection is essential because parasomnias frequently resolve with treatment, such as continuous positive airway pressure therapy in the case of OSA.3

Classification

Parasomnias are classified by the sleep stage in which they occur—NREM or REM.1 Table 1 provides a list of parasomnias classified by sleep stage.2,46

Table 1 Parasomnias by Sleep Stage

Sleep stageParasomnias
NREMConfusional arousals

Sleep-related eating disorders

Sleep talking (somniloquy)

Sleep terrors (night terrors)

Sleepwalking (somnambulism)
REMNightmare disorder

REM sleep behavior disorder

Sleep paralysis

NREM = non–rapid eye movement.

Information from references 2 and 4-6.

NREM PARASOMNIAS

NREM parasomnias include confusional arousals, sleep-related eating disorders and sexual behaviors, sleep terrors, and sleepwalking. (Clinicians should note that sleep-related eating disorders, though less common, can be an adverse effect of Z-drugs that requires careful monitoring during therapy.1,2,4) NREM parasomnias typically arise from partial arousals during deep sleep and are influenced by sleep deprivation, stress, and external stimuli.1 They are more common in children but can persist into adulthood.1,5

Behavioral and psychological therapies for NREM parasomnias, including hypnosis, psychotherapy, sleep hygiene, education, relaxation techniques, scheduled awakenings, and mindfulness, are the first-line treatments.7 Hypnosis and psychotherapy are the most commonly discussed approaches, with evidence supporting their potential to reduce episodes by addressing stress and sleep deprivation.7 Multicomponent cognitive behavior therapy (CBT), sleep hygiene, and scheduled awakenings also show promise.8,9 However, the evidence is limited because of retrospective study designs and inconsistent outcome measures.7 Pharmacologic treatment is reserved for severe cases.7

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.